CDEK by Data4ThePeople

Sign in Sign up

← All organizations

GlycoMimetics, Inc.

For profitWebsite ↗

Also known as: GlycoMimetics Incorporated

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 6, 2022

Timeline

2000s

Jun 1, 2003
GlycoMimetics, Inc.— Founded

Drugs by trial phase (11 distinct, 16 trials)

Phase 3 (1 own, 0 via acquisition)

uproleselan

Phase 2 (6 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (16)

NCT05569512CollaboratorPhase 1/Phase 2Oct 6, 2022
NCT05057221CollaboratorPhase 1/Phase 2Nov 30, 2021
NCT04964505CollaboratorPhase 1Jul 2, 2021
NCT04682405CollaboratorPhase 2Mar 31, 2021
NCT04197999Lead sponsorPhase 1Nov 21, 2019
NCT03616470Lead sponsorPhase 3Sep 30, 2018
NCT03606447Lead sponsorPhase 1Aug 31, 2018
NCT02931214Lead sponsorPhase 1Aug 1, 2016
NCT02744833Lead sponsorPhase 1/Phase 2Jul 1, 2016
NCT02811822Lead sponsorPhase 1Jun 1, 2016
NCT02703051Lead sponsorPhase 1Nov 1, 2015
NCT02306291Lead sponsorPhase 1/Phase 2Mar 1, 2015
NCT02271113Lead sponsorPhase 1Oct 1, 2014
NCT02168595Lead sponsorPhase 1Jun 1, 2014
NCT01119833Study directorPhase 2May 1, 2010

Details

Founded: Gaithersburg, MD, US Jun 1, 2003
Last known activity: Oct 6, 2022